Search results
Major Bio-mechanoid
Fandom· 1 hour agoThe Major Bio-mechanoid (colloquially known as the "Walker" by Earth Defense Force soldiers) is a very dangerous enemy featured in many Serious Sam...
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Zacks via Yahoo Finance· 9 hours agoThe ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is...
Why Bio-Path Stock Is Soaring - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga· 7 hours agoBio-Path Holdings, Inc. BPTH shares are trading higher Thursday after the company announced the...
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
NewMediaWire via Yahoo Finance· 4 hours agoCOLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S...
Telesis Bio stock slips amid new CEO (NASDAQ:TBIO)
Seeking Alpha· 7 hours agoTelesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here.
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
WPRI Providence· 12 hours agoEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class ...
Investors who lost money on bluebird bio, Inc. (BLUE) should contact Levi & Korsinsky about pending...
Morningstar· 7 hours agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE ...
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Zacks via Yahoo Finance· 2 days agoBio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma...
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace· 9 hours agoBio-Path (NASDAQ:BPTH) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This...
Equities Analysts Issue Forecasts for Gritstone bio, Inc.’s Q1 2024 Earnings (NASDAQ:GRTS)
ETF DAILY NEWS· 17 hours agoGritstone bio, Inc. (NASDAQ:GRTS – Free Report) – Equities researchers at B. Riley issued their Q1 2024 earnings estimates for Gritstone bio in a report ...
